| Literature DB >> 32582621 |
Sundas Bahar Yaqoob1, Rohana Adnan2, Raja Muhammad Rameez Khan3, Mohammad Rashid2.
Abstract
Herein, the role of metal-based nanoparticles (NPs) in biomedical analysis and the treatment of critical deceases been highlighted. In the world of nanotechnology, noble elements such as the gold/silver/palladium (Au/Ag/Pd) NPs are the most promising emerging trend to design bioengineering materials that could to be employed as modern diagnostic tools and devices to combat serious diseases. NPs are considered a powerful and advanced chemical tool to diagnose and to cure critical ailments such as HIV, cancer, and other types of infectious illnesses. The treatment of cancer is the most significant application of nanotechnology which is based on premature tumor detection and analysis of cancer cells through Nano-devices. The fascinating characteristic properties of NPs-such as high surface area, high surface Plasmon resonance, multi-functionalization, highly stable nature, and easy processing-make them more prolific for nanotechnology. In this review article, the multifunctional roles of Au/Ag/Pd NPs in the field of medical science, the physicochemical toxicity dependent properties, and the interaction mechanism is highlighted. Due to the cytotoxicity of Ag/Au/Pd NPs, the conclusion and future remarks emphasize the need for further research to minimize the toxicity of NPs in the bio-medicinal field.Entities:
Keywords: gold; nanoparticles; palladium; physico-chemical toxicity; silver; toxicity mechanism
Year: 2020 PMID: 32582621 PMCID: PMC7283583 DOI: 10.3389/fchem.2020.00376
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Spherical to Nanostar morphology of AuNPs, Functionalization by Antibody, Carbohydrate, DNA/RNA, peptide, loading with drugs, and used for probing Image.
Figure 2Application of AuNPs in medicinal science.
AuNPs antibacterial activity with their therapeutic influence.
| AuNPs | Effectively work against bacterial infection | Shaikh et al., | |
| AuNPs | Actively work against | Zhou et al., | |
| AuNPs | NPs were vigorous against Gram- positive, Gram- negative multi-drug resistant pathogens | Li et al., | |
| AuNPs | Active against bacterial infection | Shamaila et al., | |
| AuNPs | Actively work against bacterial infection | Dasari et al., | |
| AuNPs | Actively inhibited the bacterial growth | Lima et al., | |
| AuNPs | Active against | MubarakAli et al., | |
| AuNPs shared properties with ampicillin | Actively work against the bacteria | Saha et al., | |
| AuNPs collective properties with streptomycin | Potentially work against the bacteria | Saha et al., | |
| AuNPs shared properties with kanamycin | Potentially work against the bacteria | Saha et al., | |
| AuNPs collective properties with levofloxacin | Inhibited the bacterial growth | Bagga et al., | |
| AuNPs shared properties with vancomycin | - | Selectively bind the cells of Gram-positive and negative Bacteria, Antibiotic-resistant bacteria | Gu et al., |
| Light-absorbing AuNPs conjugated with precise antibodies | Selective killing of bacterium | Zharov et al., | |
| AuNPs shared properties covered with cefaclor | Effective antibacterial activities against Gram+ive and Gram-tive bacteria | Zhang et al., | |
| AuNPs shared properties with gentamicin | Active against | Rai et al., | |
| AuNPs combined with gentamicin | - | Excellent antibacterial activities | Burygin et al., |
| AuNPs synthesize by using | - | Improved antibacterial activities | Rajathi et al., |
| AuNPs synthesize through using aqueous moringa oleifera leaves | Effective against bacterium | Prasad and Elumalai, | |
| AuNPs synthesize from A. comosus extract | - | Useful decontamination methods for inhibiting the bacterial growth | Bindhu and Umadevi, |
| AuNPs Synthesize by using with ofloxacin | - | Greater bactericidal property | Ahmed et al., |
| AuNPs Synthesize by using banana peel extract | - | Improved antibacterial activity | Bankar et al., |
Figure 3(A) A systematic representation of preparation of PdNPs, functionalized by surface coating of thiolate chitosan oligosaccharide Pd@COS NPs and followed by functionalization with RGD peptide. (B) A schematic representation of Pd@COS-RGD showing the thotothermal ablation and photoacoustic imaging at tumor site [Adapted from (Bharathiraja et al., 2018), with permission of Springer Nature].
AuNPs application in cancer cell diagnosis, treatment methods, and its advantages.
| AuNPs | 15 | pAb and mAb anti-CEA antibodies, | MCF7 cells | SERS immunoassay | Different immunoassay method | Chon et al., |
| AuNPs | 35 | anti-EGFR | Oral epithelial living Cancerous cell | SPR | Valuable molecular sensors | El-Sayed et al., |
| AuNPs | 20 | Heparin | Epithelial | Imaging | therapeutics and Imaging | Shi et al., |
| AuNPs | - | folic acid, fluorescein isothiocyanate | Liver cells-imaging | Imaging | Possible CT imaging | Sun et al., |
| AuNPs | 15 | Functionalized shiny carbon electrodes | Lung and liver cancer, | Electrochemical and contact-based angle measurements | Fast identification and vastly sensitive exposure for cancerous cell | He et al., |
| AuNPs | 30 | ENO1 antibodies | Lung cancer | Electrochemical immune sensor | Measurable tests protein and cancerous biomarkers | Ho et al., |
| AuNPs | 100 | Anticarcinogen-embryonic antibodies | Cancer | ELISA | Premature diagnosis of cancer | Zhou et al., |
| AuNPs | 20 | kinase C (PKC-alpha) peptides | Breast cancer | GNP- colorimetric assay | Preliminary screening throughout cancer diagnosis | Raghavendra et al., |
| AuNPs | 15 | anti-CA15-3-HRP antibodies | Breast cancer | ELISA | Detection of cancerous cells | Ambrosi et al., |
| AuNPs | 90 | EGF-ligand and tag Raman receptors | Flow tumors | SERS | Novel clinical device for managing of patients | Wang et al., |
| AuNPs | 25 | anti-EGFR | Paracervical cancer | Illumination microscopy, | Influential device for detecting cellular, molecular variations | Rahman et al., |
| AuNPs | 15 | Single-chain variable part | Oral cancer | SERS | Saliva-assay for initial analysis of oral Cancerous cells | Kah et al., |
| AuNPs | 60 | anti-EGFR | Head-and-neck | SERS | Optical and EM enquiries for tumor detection | Conde et al., |
| AuNPs | 45 | Her-2/neu antigen | Prostate cancer detection | Difference photoacoustic imaging | Filmic device for molecular and structural information | Agarwal et al., |
| AuNPs | 15 | F19 monoclonal antibodies | Pancreatic adenocarcinoma | Light sprinkling, size prohibiting chromatography | Labeling method | Eck et al., |
| AuNPs | 20 | Aptamer | Leukemia and lymphoma | Spectroscopic method | Primary and precise exposure of cancer | Medley et al., |
EGF, endothelial growth factor; SPR, surface plasmon resonance; EGFR, endothelial growth factor receptor; HER, human epidermal growth factor receptor; ScFv: single chain variable fragment; CT, computed tomography; ELISA, enzyme linked immune sorbant assay; SERS, surface enhance Raman scattering; ENO1, alpha-enolase; SCCHN: squamous cell carcinoma of the head and neck; PC-3, prostate cancer cells; pAb, polyclonal antibody; mAb, monoclonal antibody; PEG, poly ethylene glycol; CEA, carcinoembryonic antigen.
AgNPs function in the treatment of infections.
| AgNPs | Malaria | Prevention of growth of | Murugan et al., |
| Leishmaniasis | Limitation of proliferation and metabolic activities of promastigotes. | Zahir et al., | |
| Helminth infections | Improved anthelmintic activities in contradiction of worm | Nadhman et al., | |
| HIV | Inhibition of CD4-based virion binding, fusion, and infection | Elechiguerra et al., | |
| Herpes | Virus duplication was reserved | Hu et al., | |
| Herpes | Reserve of viral access into cell and inhibition of ensuing infection | Baram-Pinto et al., | |
| Hepatitis | Interface with the HBV viral units subsequent in reduction of production of HBV RNA and extra-cellular | Lara et al., | |
| Influenza | Active against influenza viruses | Rafiei et al., | |
| Influenza | Active against influenza A virus | Taubenberger and Morens, | |
| AgNPs synthesize through biological approaches by using fungi, algae, bacteria and virus | Bacterial infection | Excellent antibacterial activities | Shirley et al., |
| AgNPs and amoxicillin, azithromycin, clarithromycin, linezolid, or vancomycin | Bacterial infection | Better synergistic antibacterial effects against methicillin-resistant | Akram et al., |
| AgNPs and gentamicin and penicillin | Bacterial infection | Exceptional antibacterial properties against animal bacterial infections, | Smekalova et al., |
| AgNPs mixture with lactam; quinolone; aminoglycoside and polykeptide | Bacterial infection | Active against drug-resistant bacteria | Deng et al., |
| AgNPs mixture with amoxicillin | Bacterial infection | Excellent synergistic effects against | Li et al., |
| AgNPs shared with polymyxin B and rifampicin | Bacterial infection | High synergistic effects against Acinetobacter, baumannii infection. | Srinivasan et al., |
| AgNPs in urinary catheter | Bacterial infection | Active NPs against bacteria that are answerable for urinary tract infections. | Wan et al., |
| Nanowires of AgNPs | Bacterial infection | Nano-cube AgNPs showed the highest antibacterial activities. | Romaniuk and Cegelski, |
| Hexagonal and nanoplates AgNPs | Bacterial infection | Hexagonal-shaped AgNPs were actual against | Hong et al., |
| Rod-shaped AgNPs | Bacterial infection | Triangular shaped revealed high antibacterial activities against | Pal et al., |